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chondrocyte secreted proteins using the stable isotope labelling by amino
acids in cell culture (SILAC) technique.
Methods: Cartilage obtained from patients undergoing joint replacement,
or from patients with no history of joint disease was provided by the
Tissue Bank and the Autopsy Service at CHU A Coruña. The study was
approved by the local Ethics Committee. Chondrocytes released from car-
tilage by enzymatic digestion were recovered and plated at low density
in basic SILAC medium (Silantes) supplemented with antibiotics and 10%
FBS dialyzed. In the case of light media, standard L-lysine (146 mg/L) and
L-arginine (28 mg/L) were used, while in the heavy media isotope-labelled
L-lysine (13C6), and isotope-labelled L-arginine (13C6,15N4) were used. When
complete incorporation of the heavy isotope was achieved in the cells (2-3
weeks), normal (N) chondrocytes were treated with CS 200μg/mL and
then stimulated with IL-1β 5ng/mL, while osteoarthritic (OA) chondrocytes
were treated with CS 200μg/mL alone. 48 hours later, conditioned media
were collected and their proteins were concentrated and quantiﬁed. Heavy
and light samples were mixed 1:1, and 4 μg of each mixed sample
were in-solution reduced, alkylated and digested with trypsin. Separation
and analysis of the resulting tryptic peptide mixtures was performed by
nanoscale reversed-phase-LC-MS/MS. The identiﬁcation and quantiﬁcation
of proteins was carried out with Protein Pilot software, which detects the
heavy/light peak pairs and calculates the heavy/light ratios based on the
peak areas. Identiﬁcations with a probability score higher than 95% and
quantiﬁcations with a p value ≤0.05 were included in the results list.
Results: Database search (UniprotKB/Swissprot) allowed us the identiﬁca-
tion of 39 different proteins in the OA chondrocyte secretome and 70 in
N chondrocyte secretome. Interestingly, in both cases the most abundant
protein was cartilage glycoprotein 39, which has been previously related
with OA pathogenesis. For biological and functional analysis we considered
only those proteins detected in all replicates with a heavy/light ratio ≥1.2
or ≤0.8. In OA chondrocytes, chondroitin sulfate mainly improves the an-
abolic/catabolic balance of the extracellular cartilage matrix, by increasing
the level of structural proteins like collagens, decorin, lumican, vimentin
and ﬁbronectin. In N chondrocytes stimulated with IL1β, CS appears to
act primarily as an anti-inﬂammatory drug. We show in this work how
CS reduces inﬂammation by two mechanisms: directly, by decreasing the
presence of potent inﬂammatory mediators like IL6 (ratio=0.6), and also
indirectly, by increasing proteins such as tumor necrosis factor α-induced
protein (TSG6, ratio=3). TSG6 plays a crucial role in extracellular matrix
formation, inﬂammatory cell migration and cell proliferation. It’s a key
component of a negative feedback loop operating through the protease
network which reduces matrix degradation during OA process. The mech-
anism driven by TSG6 leads to a decrease in proMMPs activation, which
might protect cartilage from extensive degradation even in the presence of
acute inﬂammation (represented in our case by a high level of IL1β).
Conclusions: We have carried out the ﬁrst pharmacoproteomic study
using a quantitative proteomics approach (SILAC), based on the metabolic
labelling of the cells, to study the effect of CS on chondrocyte secretome.
Our ﬁndings provide novel information about the mechanisms that may
exert the in vivo beneﬁcial effects of CS on the OA disease process. This
work also illustrates that chondrocyte secreted proteins are an attractive
sub-proteome for the discovery of new targets of CS in OA therapy.
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Purpose: Previous in-house proteomic work identiﬁed several secreted
proteins from equine cartilage explants in response to recombinant
equine interleukin-1 beta (IL-1β) with or without the non-steroidal anti-
inﬂammatory drug, carprofen. The aim of this study was to validate the
presence of six of these proteins by western blotting. We also used quan-
titative densitometry to determine the effects of IL-1β, with or without
carprofen treatment, on levels of these proteins in the cartilage secretome
compared to control explants.
Methods: Cartilage explants were obtained from weight-bearing regions
of metacarpophalangeal joints of horses euthanized for purposes other
than for research. Explants were either incubated alone (control: C), with
IL-1β (10ng/ml), or in combination with IL-1β and carprofen (IL-1β+ CA,
10ng/ml and 100μg/ml respectively) at 37°C for 5 days. Culture medium
supernatants were collected and each sample divided into two aliquots.
One aliquot underwent tryptic digestion and high-throughput proteomic
analysis by ESI (Electrospray Ionisation) mass spectrometry using a Bruker
HCT PTM discovery ion trap instrument. Comparative proteomic analysis
of the supernatants identiﬁed a number of potentially relevant proteins.
The remaining corresponding aliquots were resolved on 1-D gels and
either silver stained to compare their electrophoretic proﬁles or used for
western blotting to validate protein expression. Six of the most commonly
identiﬁed proteins were selected for quantitative validation by western
blotting; cartilage oligomeric matrix protein (COMP), thrombospondin-1
(TSP-1), clusterin (mature and precursor forms), cartilage intermediate
layer protein-1 (CILP-1) and the matrix metalloproteinases MMP-1 and
MMP-3.
Results: SDS-PAGE and silver staining revealed qualitative differences
between the electrophoretic proﬁles of samples exposed to the different
treatments. Western blotting conﬁrmed the presence of COMP, TSP-1,
clusterin, clusterin precursor, CILP-1, MMP-1 and MMP-3 in explant su-
pernatants. Quantitative densitometry indicated that TSP-1, MMP-1 and
MMP-3 levels were increased in IL-1β and IL-1β+CA samples compared
to controls. Carprofen reduced MMP-1 and MMP-3 levels in IL-1β+CA
compared to IL-1β treatment alone. CILP-1 and clusterin levels remained
unchanged in all treatments, although the clusterin precursor was de-
creased in IL-1β samples.
Figure 1
Conclusions: The authors’ previous proteomic work has identiﬁed several
relevant extracellular matrix proteins in explant supernatants stimulated
with IL-1β. This study conﬁrmed the presence of six of these proteins
by quantitative western blotting and densitometry. Many of the identi-
ﬁed proteins have well-known matrix functions including participation
in cell-matrix and matrix-matrix interactions (i.e. TSP-1, COMP, CILP),
matrix turnover (MMP-1, MMP-3) and extracellular molecular chaperone
activity (clusterin). The validation described in this study suggests that
this high-throughput proteomic system provides a useful tool to identify
candidate proteins from the cartilage secretome for further quantitative
analysis using western blotting.
Acknowledgements: This work was supported by the BBSRC (BBS/S/M/
2006/13141) and the WALTHAM Centre for Pet Nutrition.
504
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Purpose: The aim of this study is to standardize the stable isotope labelling
by amino acids in human chondrocytes cell culture (SILAC) technique, and
to apply this novel strategy for the study of osteoarthritis (OA) patho-
physiology. To attain this objective, we have used an in vitro model of
inﬂammation based on the stimulation of human articular chondrocytes
with the cytokine Interleukin-1β (IL1β), a key OA mediator.
Methods: Cartilage obtained from patients with no history of joint disease
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was provided by the Tissue Bank at CHU A Coruña. The study was approved
by the local Ethics Committee. The SILAC technique is based on the incor-
poration of stable isotope labelled amino acids into the whole proteome,
including its secretome (cell-conditioned medium). Chondrocytes released
from cartilage by enzymatic digestion were recovered and plated at low
density in SILAC medium (Silantes), lacking lysine and arginine. In the case
of light media, we supplemented it with the standard amino acids, while
in the heavy media isotope-labelled L-lys (13C6) and L-arg (13C615N4) were
employed. Chondrocytes were used at week 2-3 in primary culture, after
making them quiescent by incubation in a medium containing 0% FBS for
24h. Titration assays were performed to ensure a 100% labelling of the pro-
teins without chondrocyte de-differentiation. Cells were then washed and
incubated in serum-free medium with IL-1β at 5 ng/mL for 48 hours. Then,
conditioned media were collected and intracellular proteins were extracted.
Heavy and light secretome samples were mixed 1:1, and 4 μg of each
mixed sample were directly in-solution reduced, alkylated and digested
with trypsin. In the case of intracellular extracts, heavy and light mixed
proteins were ﬁrst fractionated by SDS-PAGE. Then, the whole lane was
excised into 16 bands which were subsequently processed for in-gel tryptic
digestion. In both cases, separation of the resulting tryptic peptide mixtures
was performed by nanoscale reversed-phase-LC-MS/MS. The identiﬁcation
and quantiﬁcation of proteins (by calculating the heavy:light ratios for each
peptide) was carried out with Protein Pilot software, considering signiﬁcant
changes those with a ratio ≥1.2 or ≤0.8, and a p value ≤0.05.
Results: Collection and LC/MS analysis of the chondrocyte secreted proteins
allowed the identiﬁcation of 76 different proteins. 65 of them could also
be quantiﬁed and 32 presented statistically signiﬁcant differences between
basal and IL1β-treated samples: 17 were increased and 15 decreased.
Most of the identiﬁed proteins are cartilage ECM components (27%), such
as collagens, lumican, proteoglycans or the cartilage oligomeric matrix
protein, which clearly demonstrates the usefulness of chondrocyte secre-
tome analysis for the study of cartilage ECM metabolism. We could also
detect a high number of growth factors (19%), matrix remodelling proteins
(14%), structural proteins (11%) and cytokines (8%). On the other hand,
the analysis of chondrocyte intracellular proteins allowed the identiﬁcation
of 347 different proteins. All of them were quantiﬁed (except 4), and 40
proteins were characterized as signiﬁcantly modulated by IL1β: 50% were
increased and 50% decreased by the treatment. Interestingly, almost 30%
of the downregulated proteins are related with cytoskeletal remodelling,
indicating the changes in chondrocyte morphology caused by IL1β. The
proteins increased are related with a number of cellular processes like
metabolism, stress response, defence or signal transduction.
Conclusions: We have standardized the SILAC technique for the proteomic
analysis of human primary cartilage cells, and we have applied this tech-
nology to study the effect of the proinﬂammatory cytokine IL-1β, a key
molecule in the OA process, on the chondrocyte secretome and proteome.
The obtained information will increase knowledge about OA pathogenesis,
and already points out a number of possible markers of the disease.
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Purpose: The progress in proteomics technology development during the
last decade has made tissue proteomics available also for extracellular
matrices such as cartilage and bone. Some of the obvious targets for carti-
lage proteomics include surveillance and search for alterations in disease.
Characterization of molecular differences between cartilage subtypes will
provide a background for understanding different functionality and disease.
Methods: To provide information on differences between cartilage and
related tissues from different origins we have studied the protein patterns
at a quantitative level in various cartilages including three joints (femoral
head, tibial knee, humerus shoulder), rib, trachea as well as meniscus,
nucleus pulposus and annulus ﬁbrosus. Our proteomics approach includes
tissue extraction, trypsin digestion and 2D LC-separations coupled to tan-
dem mass spectrometry for identiﬁcation and quantiﬁcation. The study is
based on quantitative isotopic labeling (ITRAQ) allowing in each application
three tissue samples of some 5 mg to be quantiﬁed simultaneously for
some 200 identiﬁed proteins relative to a constant reference pool of several
tissues. The strategy allowed us to compare amounts of the individual
proteins between the 8 tissues from ﬁve individuals.
Results: Multivariate statistical analysis of the data, also when restricted
to extracellular matrix proteins not including growth factors, enzymes,
intracellular proteins and plasma proteins from e.g. liver, revealed sig-
niﬁcant differences between all tissues in this study and also showed
some differences between the articular cartilages. The various tissues form
separate clusters based on the data obtained. There are many examples
of proteins that show manyfold differences in abundance between tissues.
Notably, matrilin-1 is extremely speciﬁc for rib and tracheal cartilage.
Lubricin was found to be some 10-fold higher in the nucleus and only
slightly lower in the annulus compared to all the other tissues. Examples of
other proteins that showed marked differences in tissue distributions are
asporin, ﬁbromodulin, lumican and COMP.
Conclusions: In this work a quantitative proteomic approach was used
to characterize molecular differences between different cartilage subtypes.
The results from this global characterization of cartilage will have a major
impact on our understanding of cartilage biology and pathology.
Rehabilitation
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Purpose: Exercise therapy is a conservative treatment for osteoarthritis of
the knee (OAk) of which the effectiveness is well substantiated: exercise
signiﬁcantly diminishes the pain and improves the patient’s functioning.
No clear explanation is given for this health improving effect of exercise.
The present systematic literature review aims to provide an overview of
the theoretical models that are put forward to explain the treatment effects
of exercise in OAk as well as their scientiﬁc foundation.
Methods: We included all studies collected in Cochrane reviews empha-
sizing on exercise therapy for OAk. Therefore we used the search engine
of the Cochrane Library website (http://www.cochrane.org/; keywords: os-
teoarthritis, exercise, knee). We also collected guidelines that are included
in the Physiotherapy Evidence Database (http://www.pedro.org.au/) that
were published since 2000 and that are related to the treatment of OAk
(keywords: osteoarthritis, practice guideline, body part: lower leg or knee).
If exercise therapy is recommended in these guidelines, the studies that
were used to empower this advice, were included in this work. The in-
troduction and discussion parts of the included studies were subsequently
screened for plausible explanations supporting inﬂuences of exercise on
OAk. We aimed to provide an overview of general opinions concerning the
theoretical models.
Results: Three Cochrane reviews and 7 guidelines were identiﬁed. After
eliminating double references, 37 full papers were included in the study.
Potential explanations for the effects of exercise for OAk were mentioned in
14 papers. A better knee stability, as well as weight loss and the improved
energy absorbing quality of the peri-articular muscles of the knee have
been proposed as mechanisms that decrease tear and shear stresses of the
articular cartilage, ﬁnally resulting in pain reduction. Improved stability of
the osteoarthritic knee was mentioned in 8 papers as a possible explana-
tion. One author suggests that the improved energy absorbing quality of the
muscles of the knee after exercise may contribute to a decreased amount
of energy that is transmitted through the subchondral bone and articular
cartilage. Weight loss following exercise is hypothesized in 3 studies as
a reason for the treatment effects of exercise in OAk. The observation
that exercise can be related to an improved mental state was proposed
as an explanation for the subjective health improving effect of exercise in
4 papers. In 3 papers higher cartilage proteoglycan content and improved
joint ﬂuid viscosity is put forward to explain the improvements in pain and
functioning.
Conclusions: Several theoretical models have been found in the litera-
ture to explain the health improving effects of exercise in patients with
osteoarthritis of the knee. The most cited explanation is the improved
stability of the knee, providing a decrease in tear and shear stresses of the
articular cartilage. More research is needed to support the models.
